The treatment of attention-deficit hyperactivity disorder: An annotated bibliography and critical appraisal of published systematic reviews and metaanalyses

Canadian Journal of Psychiatry

Volumn 44, Issue 10, 1999, Pages 1025-1035

  Jadad, Alejandro R ^a   Booker, Lynda ^a   Gauld, Mary ^a   Kakuma, Ritsuko ^a   Boyle, Michael ^a   Cunningham, Charles E ^a   Kim, Marie ^a   Schachar, Russell ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Adverse effects; Attention deficit; Behavioural therapy; Hyperactivity; Metaanalysis; Stimulants; Systematic review; Treatment

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE; CAFFEINE; CARBAMAZEPINE; CHLORPROMAZINE; CLONIDINE; CLORGYLINE; DESIPRAMINE; DEXAMPHETAMINE; FENFLURAMINE; FLUOXETINE; GUANFACINE; HALOPERIDOL; HYDROXYZINE; IMIPRAMINE; LEVODOPA; LITHIUM; MAGNESIUM; MEPROBAMATE; MESORIDAZINE; METHYLPHENIDATE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NOMIFENSINE; NORTRIPTYLINE; PARGYLINE; PEMOLINE; SELEGILINE; UNINDEXED DRUG;

ADOLESCENT; ANOREXIA; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; GROWTH INHIBITION; HEALTH CARE POLICY; HUMAN; INSOMNIA; LIVER TOXICITY; META ANALYSIS; REVIEW; TIC; TREATMENT INDICATION;

EID: 0033399574     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379904401009     Document Type: Review

References (46)

1. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36(Suppl 10):85S-121S.
2. Goldman LS, Genel M, Bezman RJ, and Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279:1100-1107.
3. Barkley RA. Attention-deficit/hyperactivity disorder. In: Mash EJ, Barkley RA, editors. Child psychopathology. New York: Guilford; 1996. p 63-112
4. Weinberg WA, Brumback RA. The myth of attention-deficit-hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurol 1992;7:431-45.
5. http://www.healthy.net/library/books/ullman/chap3.htm.
6. Kewley GD. Personal paper: attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain. BMJ 1998;316:1594-6.
7. Orford E. Commentary: diagnosis needs tightening. BMJ 1998;316:1594-6.
8. Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M. Methodology and reports of systematic reviews and meta-analysis: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998;280:278-9.
9. Berlin JA, for the University of Pennsylvania Meta-analysis Blinding Study Group. Does blinding of readers affect the results of meta-analyses? Lancet 1997;350:185-6.
10. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991;44:1272-8.
11. Jadad AR, McQuay HJ. Meta-analysis to evaluate analgesic interventions: a systematic qualitative review of their methodology. J Clin Epidemiol 1996;49:235-43.
12. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279:1566-70.
13. DuPaul GJ, Eckert TL. The effects of school-based interventions for attention deficit hyperactivity disorder: a meta-analysis. School Psychology Review 1997;26:5-27.
14. Kavale K. The efficacy of stimulant drug treatment for hyperactivity: a metaanalysis. Journal of Learning Disabilities 1982; 15280-9.
15. Kavale K A, Fomess SR. Hyperactivity and diet treatment: a meta-analysis of the Feingold hypothesis. Journal of Learning Disabilities 1983;16:324-30.
16. Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD. a meta-analytic review. J Child Psychol Psychiatry 1996;37:971-87.
17. Ottenbacher K J, Cooper HM. Drug treatment of hyperactivity in children. DevMed Child Neurology 1983;25:358-66.
18. Schachar R, Tannock R. Childhood hyperactivity and psychostimulants: a review of extended treatment studies. J Child Adolesc Psychopharmacol 1993;3:81-97.
19. Shevell M, Schreiber R. Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatr Neurol 1997;16:4-6.
20. Silva RR, Munoz DM, Alpert M. Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. J Am Acad Child Adolesc Psychiatry 1996;35:352-8.
21. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharnacotherapy of attention-deficit hyperactivity disorder across the life. J Am Acad Child Adolesc Psychiatry 1996;35:409-32.
22. Stein MA, Krasowski M. Leventhal BL, Phillips W, Bender BG. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Arch Pediatr Adolesc Med 1996;150:284-8.
23. Thurber S, Walker CE. Medication and hyperactivity: a meta-analysis. J Gen Psychol 1983; 108(1 st Half):79-86.
24. Wilens T E, Biederman J, Spencer T J, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 1995;15:270-9.
25. Biederman J, Gonzalez E, Bronstein B, DeMonaco H, Wright V. Desipramme and cutaneous reactions in pediatric outpatients. J Clin Psychiatry 1988;49:178-83.
26. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenctics 1995;5:121-41.
27. Campbell M, Cueva JE. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: I. J Am Acad Child Adolesc Psychiatry 1995:34:1124-32.
28. Diamond GS, Serrano AC, Dickey M, Sonis WA. Current status of family-based outcome and process research. J Am Acad Child Adolesc Psychiatry 1996;35:6-16.
29. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1143-6.
30. Lock J, Strauss GD. Psychiatric hospitalization of adolescents for conduct disorder, Hospital & Community Psychiatry 1994;45:925-8.
31. Peterson BS. Neuroimaging in child and adolescent neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry 1995; 34:1560-76.
32. Priest RG, Gimbrett R, Roberts M, Steinert J. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Acta Psychiatr Scand 1995;(Suppl386):40-3.
33. Richters JE, Arnold IE, Jensen PS. Abikoff H, Conners CK, Greenhill LL, and others. NIMH Collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry 1995;987-1000.
34. Spencer T, Biederman J, Wilens T, Guite J, Harding M. ADHD and thyroid abnormalities: a research note. J Child Psychol Psychiatry 1995;36:879-85.
35. Swanson JM, McBurnett K. Wigal T, Pfiffner LJ, Lerner MA, Williams L, and others. Effect of stimulant medication on children with attention deficit disorder: a "review of reviews." Exceptional Children 1993;60:154-62.
36. Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995;274:1617-21.
37. Corkum P, Tannock R, Moldofsky H. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1998; 37:637-46.
38. Cantwell DP. ADHD through the life span: the role of bupropion in treatment J Clin Psychiatry 1998;Suppl 4:4-94.
39. Miller A, Lee SK, Raina P, Klassen A, Zupancic J, Olsen L. A review of therapies for attention-deficit/hyperactiviry disorder. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). RFP #ADHD-1196 http:// www.ccohta.ca/main-e.html.
40. Pelham WE Jr, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1998;27:190-205.
41. Wilens TE, Biederman J, Spencer TJ. Pharmacotherapy of attention deficit hyperactivity disorder in adults. CNS Drugs 1998;May(5):347-56.
42. CrenshawTM. Attention deficit hyperactivity disorder and the efficacy of stimulant medication: a meta-analysis. Dissertation. Abstiacts.International.: Section.B.: the Sciences and Engineering 1997; Sep(3-B):1524.
43. Swanson JM, McBurnett K, Christian DL, Wigal T. Stimulant medications and the treatment of children with ADHD. In: Ollendick TH, Prinz RJ, editors. Advances in clinical child psychology. Volume 17. New York: Plenum Press; 1995.
44. Mulrow C, Cook D. Systematic reviews: synthesis of best evidence for health care decisions. Philadelphia: American College of Physicians; 1998.
45. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J 1988;138:697-703.
46. Sacks HS, Berner J, Reitman D, Pagano D, Chalmers TC. Meta-analysis of randomized control trials. In: Bailar JC, Mosteller F, editors. Medical uses of statistics 2nd ed. Boston: NEJM Books; 1992.